
Gastroenterologist

No OPD information available
Colorectal Cancer
Gastroesophageal Junction Cancer
Magnesium Deficiency
Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Stomach Cancer
Cerebral Hypoxia
Cholangiocarcinoma (Bile Duct Cancer)
Diarrhea
Esophageal Cancer
Familial Colorectal Cancer
Gastrointestinal Stromal Tumor
Hypertension
Liver Cancer
Lung Metastases
Pancreatectomy
Niall C. Tebbutt is a male doctor who helps patients with different types of cancers and other health issues like diarrhea and hypertension. He is skilled in treating conditions like Colorectal Cancer, Pancreatic Cancer, and Liver Cancer.
Dr. Tebbutt is known for his special abilities in treating diseases of the digestive system, such as Stomach Cancer and Esophageal Cancer. He also helps patients with brain-related problems like Cerebral Hypoxia.
Patients trust Dr. Tebbutt because he communicates well with them, explaining their conditions and treatment options clearly. He listens to their concerns and works with them to find the best solutions for their health.
To stay updated with the latest medical knowledge, Dr. Tebbutt reads research papers and attends conferences. This helps him provide the most effective treatments to his patients.
Dr. Tebbutt works closely with other medical professionals, collaborating on patient care and sharing knowledge. His relationships with colleagues are important in providing comprehensive care to patients.
Dr. Tebbutt's work has had a positive impact on many patients' lives. His research paper on liver transplantation in liver-only metastatic colorectal cancer has contributed to improving treatment options. He is also involved in a clinical trial studying new treatments for HER2-positive Gastroesophageal Adenocarcinoma, aiming to find better ways to help patients with this type of cancer.
Overall, Dr. Niall C. Tebbutt is a dedicated doctor who uses his skills and knowledge to help patients with various health conditions, making a difference in their lives through his compassionate care and commitment to staying informed about the latest medical advancements.
Enrollment Status: Active not recruiting
Published: April 01, 2025
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
